Stockreport

UPDATE 1-US FDA grants full approval to AbbVie's ovarian cancer therapy [Yahoo! Finance]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF AbbVie's "guided missile" cancer therapy, Elahere, for patients with a type of ovarian cancer. Elahere was approved for adult patients with a type of cancer which affe [Read more]